Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05706532 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT05706532 · ClinicalTrials.gov record · last posted 2026-07-06

Cardiovascular and Cerebrovascular Control in Healthy Subjects

Study acronym: CardioSan
StatusRecruiting
PhaseNot specified
Started2023-05-29
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The aim of the study is to evaluate autonomic function and cerebrovascular control in 60 healthy subjects by means of noninvasive analysis of time series variability. To this extent, heart period, systolic and mean arterial blood pressure, cerebral blood velocity, peripheral resistances, respiration will be recorded from subjects during an orthostatic challenge. The interactions between autonomic cardiovascular function, cerebrovascular and peripheral control will be evaluated exploiting the most advanced signal processing techniques.

Amendment record 5 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 5 times since 2023-01-23; most recent amendment 2026-07-02. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2023-10-10
Status change Not Yet Recruiting→Recruitingv2
Trial Details
NCT Number NCT05706532
Lead Sponsor IRCCS Policlinico S. Donato
Conditions Healthy, Autonomic Nervous System, Cerebral Autoregulation
Enrollment 60 participants
Start Date 2023-05-29
Primary Completion 2027-10 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-06